{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:23:25Z","timestamp":1786991005208,"version":"build-2736575974"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI20C1496"],"award-info":[{"award-number":["HI20C1496"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.imlet.2022.06.008","type":"journal-article","created":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T09:31:19Z","timestamp":1655631079000},"page":"62-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sphingosylphosphorylcholine ameliorates experimental sj\u00f6gren's syndrome by regulating salivary gland inflammation and hypofunction, and regulatory B cells"],"prefix":"10.1016","volume":"248","author":[{"given":"Da Som","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Sik","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-Hyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JeongWon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoe-Sik","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-3989","authenticated-orcid":false,"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2022.06.008_bib0001","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2012.53","article-title":"Topical and systemic medications for the treatment of primary Sjogren's syndrome","volume":"8","author":"Ramos-Casals","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0002","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","article-title":"Clinical and immunological parameters of Sjogren's syndrome","volume":"17","author":"Psianou","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2022.06.008_bib0003","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary Sjogren's syndrome","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0004","article-title":"Primary Sjogren syndrome: focus on innate immune cells and inflammation","volume":"8","author":"Rizzo","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.imlet.2022.06.008_bib0005","first-page":"2438","article-title":"regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjogren's syndrome","volume":"34","author":"Li","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0006","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0961203307085248","article-title":"Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome","volume":"17","author":"Liu","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.imlet.2022.06.008_bib0007","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2249.2009.03966.x","article-title":"Cells with regulatory function of the innate and adaptive immune system in primary Sjogren's syndrome","volume":"157","author":"Szodoray","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/08916930802282651","article-title":"Quantification and molecular characterization of regulatory T cells in connective tissue diseases","volume":"42","author":"Banica","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2022.06.008_bib0009","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.4049\/jimmunol.175.12.8392","article-title":"Global natural regulatory T cell depletion in active systemic lupus erythematosus","volume":"175","author":"Miyara","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2022.06.008_bib0011","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12026-021-09171-x","article-title":"IL-10-producing regulatory B cells are present and functional in primary Sjogren patients","volume":"69","author":"Mielle","year":"2021","journal-title":"Immunol. Res."},{"key":"10.1016\/j.imlet.2022.06.008_bib0012","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41423-019-0227-z","article-title":"IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjogren's syndrome","volume":"16","author":"Lin","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0013","article-title":"The multiple roles of B cells in the pathogenesis of Sjogren's Syndrome front","volume":"12","author":"Du","year":"2021","journal-title":"Immunol"},{"key":"10.1016\/j.imlet.2022.06.008_bib0014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(94)01234-9","article-title":"Involvement of ryanodine receptors in sphingosylphosphorylcholine-induced calcium release from brain microsomes","volume":"669","author":"Dettbarn","year":"1995","journal-title":"Brain Res."},{"issue":"Pt 3","key":"10.1016\/j.imlet.2022.06.008_bib0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/bj3340641","article-title":"Intracellular calcium mobilization and phospholipid degradation in sphingosylphosphorylcholine-stimulated human airway epithelial cells","volume":"334","author":"Orlati","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.imlet.2022.06.008_bib0016","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1046\/j.1523-1755.1998.00162.x","article-title":"Ca2+ signaling induced by sphingosylphosphorylcholine and sphingosine 1-phosphate via distinct mechanisms in rat glomerular mesangial cells","volume":"54","author":"Chen","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.imlet.2022.06.008_bib0017","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0168-0102(99)00004-8","article-title":"Sphingosylphosphorylcholine increases calcium concentration in isolated brain nuclei","volume":"33","author":"Calcerrada","year":"1999","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.imlet.2022.06.008_bib0018","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0014-5793(99)01076-5","article-title":"Sphingosylphosphorylcholine induces cytosolic Ca(2+) elevation in endothelial cells in situ and causes endothelium-dependent relaxation through nitric oxide production in bovine coronary artery","volume":"457","author":"Mogami","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.imlet.2022.06.008_bib0019","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.bjp.0703190","article-title":"Distinct Ca(2+) signalling mechanisms induced by ATP and sphingosylphosphorylcholine in porcine aortic smooth muscle cells","volume":"129","author":"Chin","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0020","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cellsig.2006.01.005","article-title":"Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C","volume":"18","author":"Afrasiabi","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1016\/j.imlet.2022.06.008_bib0021","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0006-291X(05)81427-5","article-title":"Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines","volume":"181","author":"Desai","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imlet.2022.06.008_bib0022","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1083\/jcb.121.6.1385","article-title":"Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts","volume":"121","author":"Desai","year":"1993","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0023","doi-asserted-by":"crossref","first-page":"24334","DOI":"10.1074\/jbc.270.41.24334","article-title":"Sphingosylphosphorylcholine activation of mitogen-activated protein kinase in Swiss 3T3 cells requires protein kinase C and a pertussis toxin-sensitive G protein","volume":"270","author":"Seufferlein","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2022.06.008_bib0024","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/eji.200526129","article-title":"Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor","volume":"35","author":"Jin","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2567.2007.02578.x","article-title":"Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin-12","volume":"121","author":"Ceballos","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2022.06.008_bib0026","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.jidsp.5640206","article-title":"Modulation of T-lymphocyte proliferation by exogenous natural ceramides and sphingosylphosphorylcholine","volume":"4","author":"Tokura","year":"1999","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.imlet.2022.06.008_bib0027","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41401-018-0036-4","article-title":"Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases","volume":"39","author":"Ge","year":"2018","journal-title":"Acta. Pharmacol. Sin."},{"key":"10.1016\/j.imlet.2022.06.008_bib0028","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ni.2730","article-title":"Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation","volume":"14","author":"Garris","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0029","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.immuni.2007.11.017","article-title":"S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress","volume":"28","author":"Pham","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2022.06.008_bib0030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ni.1939","article-title":"The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells","volume":"11","author":"Liu","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0031","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ajpath.2011.09.027","article-title":"CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy","volume":"180","author":"Ishimaru","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0032","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nature11738","article-title":"Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress","volume":"493","author":"Arnon","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2022.06.008_bib0033","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ni1542","article-title":"Follicular shuttling of marginal zone B cells facilitates antigen transport","volume":"9","author":"Cinamon","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0034","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ni1083","article-title":"Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone","volume":"5","author":"Cinamon","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0035","doi-asserted-by":"crossref","first-page":"e9277","DOI":"10.1371\/journal.pone.0009277","article-title":"A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow","volume":"5","author":"Pereira","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2022.06.008_bib0036","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ni.2047","article-title":"The sphingosine 1-phosphate receptor S1P(2) maintains the homeostasis of germinal center B cells and promotes niche confinement","volume":"12","author":"Green","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0037","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1084\/jem.20111449","article-title":"Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers","volume":"208","author":"Wang","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2022.06.008_bib0038","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2337\/db07-0589","article-title":"Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells","volume":"57","author":"Marino","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2022.06.008_bib0039","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1203252","article-title":"Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice","volume":"191","author":"Stolp","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.it.2007.01.007","article-title":"Tipping the gatekeeper: S1P regulation of endothelial barrier function","volume":"28","author":"Rosen","year":"2007","journal-title":"Trends. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0041","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ni1269","article-title":"Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses","volume":"6","author":"Wei","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0042","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000878","article-title":"Cladribine vs other drugs in MS: merging randomized trial with real-life data","volume":"7","author":"Signori","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.imlet.2022.06.008_bib0043","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000660","article-title":"Dimethyl fumarate vs fingolimod following different pretreatments: a retrospective study","volume":"7","author":"Diem","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.imlet.2022.06.008_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.660104","article-title":"Age-related transcriptional deregulation of genes coding synaptic proteins in Alzheimer's disease Murine Model: potential neuroprotective effect of fingolimod","volume":"14","author":"Jesko","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.imlet.2022.06.008_bib0045","article-title":"The therapeutic targets of fingolimod (FTY720) are involved in pathological processes in the frontal cortex of Alzheimer's disease patients: a network pharmacology study front","volume":"13","author":"Yin","year":"2021","journal-title":"Aging. Neurosci."},{"key":"10.1016\/j.imlet.2022.06.008_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238957","article-title":"Anti-Inflammatory Treatment with FTY720 starting after onset of symptoms reverses synaptic deficits in an AD mouse model","volume":"21","author":"Kartalou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2022.06.008_bib0047","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2147\/DDDT.S293876","article-title":"FTY720 Inhibits the Development of Collagen-Induced Arthritis in Mice by Suppressing the Recruitment of CD4(+) T Lymphocytes","volume":"15","author":"Zhu","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.imlet.2022.06.008_bib0048","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0192-0561(99)00088-0","article-title":"Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats","volume":"22","author":"Matsuura","year":"2000","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0049","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clim.2010.03.428","article-title":"Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model","volume":"136","author":"Tsunemi","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0050","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.4049\/jimmunol.1401842","article-title":"FTY720 abrogates collagen-induced arthritis by hindering dendritic cell migration to local lymph nodes","volume":"195","author":"Han","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0051","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s000110050608","article-title":"Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats","volume":"49","author":"Matsuura","year":"2000","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.imlet.2022.06.008_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.663541","article-title":"Neuroprotective effects of fingolimod supplement on the retina and optic nerve in the mouse model of experimental autoimmune encephalomyelitis","volume":"15","author":"Yang","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.imlet.2022.06.008_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186463","article-title":"Morpholino analogues of fingolimod as novel and selective S1P1 ligands with in vivo efficacy in a mouse model of experimental antigen-induced encephalomyelitis","volume":"21","author":"Stepanovska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2022.06.008_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106919","article-title":"A new lipophilic amino alcohol, chemically similar to compound FTY720, attenuates the pathogenesis of experimental autoimmune encephalomyelitis by PI3K\/Akt pathway inhibition","volume":"88","author":"da Silva","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0055","first-page":"439","article-title":"FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration","volume":"2","author":"Kataoka","year":"2005","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0056","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1038\/srep05051","article-title":"Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations","volume":"4","author":"Sheridan","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2022.06.008_bib0057","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12967-020-02386-w","article-title":"FTY720 ameliorates GvHD by blocking T lymphocyte migration to target organs and by skin fibrosis inhibition","volume":"18","author":"Ryu","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.imlet.2022.06.008_bib0058","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1182\/blood-2007-05-087940","article-title":"Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)","volume":"110","author":"Taylor","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2022.06.008_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102549","article-title":"Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjogren's model","volume":"115","author":"Cohen","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2022.06.008_bib0060","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1194\/jlr.M700077-JLR200","article-title":"Sphingosylphosphorylcholine acts in an anti-inflammatory manner in renal mesangial cells by reducing interleukin-1beta-induced prostaglandin E2 formation","volume":"48","author":"Xin","year":"2007","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.imlet.2022.06.008_bib0061","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/0886022X.2016.1194142","article-title":"Antioxidant and renoprotective effects of sphingosylphosphorylcholine on contrast-induced nephropathy in rats","volume":"38","author":"Aksu","year":"2016","journal-title":"Ren. Fail."},{"issue":"2010","key":"10.1016\/j.imlet.2022.06.008_bib0062","article-title":"Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia\/reperfusion injury","author":"Herzog","year":"2010","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.imlet.2022.06.008_bib0063","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10495-020-01639-9","article-title":"Sphingosylphosphorylcholine alleviates hypoxia-caused apoptosis in cardiac myofibroblasts via CaM\/p38\/STAT3 pathway","volume":"25","author":"Li","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.imlet.2022.06.008_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118692","article-title":"MicroRNA-155-5p\/EPAS1\/interleukin 6 pathway participated in the protection function of sphingosylphosphorylcholine to ischemic cardiomyocytes","volume":"264","author":"Yao","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.imlet.2022.06.008_bib0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/HYPERTENSIONAHA.107.104802","article-title":"Low concentrations of sphingosylphosphorylcholine enhance pulmonary artery vasoreactivity: the role of protein kinase C delta and Ca2+ entry","volume":"51","author":"Snetkov","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.imlet.2022.06.008_bib0066","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12950-020-00244-6","article-title":"A novel sphingosylphosphorylcholine and sphingosine-1-phosphate receptor 1 antagonist, KRO-105714, for alleviating atopic dermatitis","volume":"17","author":"Yoon","year":"2020","journal-title":"J. Inflamm. (Lond)"},{"key":"10.1016\/j.imlet.2022.06.008_bib0067","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jcmm.16101","article-title":"Sphingosylphosphorylcholine blocks ovariectomy-induced bone loss by suppressing Ca(2+) \/calmodulin-mediated osteoclast differentiation","volume":"25","author":"Lee","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.imlet.2022.06.008_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112467","article-title":"Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjogren's syndrome","volume":"9","author":"Kern","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2022.06.008_bib0069","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1186\/ar2617","article-title":"Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjogren's syndrome in salivary glands of non-obese diabetic mice","volume":"11","author":"Gatumu","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2022.06.008_bib0070","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.4049\/jimmunol.1200385","article-title":"IL-17 and TNF-alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation","volume":"188","author":"Griffin","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0071","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","article-title":"Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells","volume":"71","author":"Hot","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2022.06.008_bib0072","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0073","doi-asserted-by":"crossref","first-page":"81860","DOI":"10.18632\/oncotarget.19899","article-title":"A native-like bispecific antibody suppresses the inflammatory cytokine response by simultaneously neutralizing tumor necrosis factor-alpha and interleukin-17A","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.imlet.2022.06.008_bib0074","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaut.2017.11.003","article-title":"Th17 cells in primary Sjogren's syndrome: pathogenicity and plasticity","volume":"87","author":"Verstappen","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2022.06.008_bib0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2022.06.008_bib0076","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12016-020-08793-7","article-title":"Immunobiology of T cells in Sjogren's syndrome","volume":"60","author":"Yao","year":"2021","journal-title":"Clin. Rev. Allergy. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0077","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/imt.13.49","article-title":"The future of B cell-targeted therapies in Sjogren's syndrome","volume":"5","author":"Cornec","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.imlet.2022.06.008_bib0078","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2249.1997.4691368.x","article-title":"High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid","volume":"109","author":"Takahashi","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0079","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1172\/JCI1230","article-title":"Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice","volume":"101","author":"Hunger","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2022.06.008_bib0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/exer.1999.0715","article-title":"Impact of gender on exocrine gland inflammation in mouse models of Sjogren's syndrome","volume":"69","author":"Toda","year":"1999","journal-title":"Exp. Eye. Res."},{"key":"10.1016\/j.imlet.2022.06.008_bib0081","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/art.21347","article-title":"Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going?","volume":"52","author":"Dawson","year":"2005","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.imlet.2022.06.008_bib0082","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.012","article-title":"The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjogren's syndrome: a critical review","volume":"51","author":"Sumida","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2022.06.008_bib0083","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0026-895X(25)14572-0","article-title":"Rat parotid gland protein kinase activation. Relationship to enzyme secretion","volume":"21","author":"Spearman","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0084","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.immunol.19.1.497","article-title":"Calcium signaling mechanisms in T lymphocytes","volume":"19","author":"Lewis","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41577-018-0110-7","article-title":"Calcium signalling in T cells","volume":"19","author":"Trebak","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0086","first-page":"143","article-title":"Role of calcium signaling in B cell activation and biology","volume":"393","author":"Baba","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0087","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nri2172","article-title":"Calcium signalling and cell-fate choice in B cells","volume":"7","author":"Scharenberg","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2022.06.008_bib0088","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.bbamcr.2018.07.002","article-title":"Calcium signaling defects underlying salivary gland dysfunction","volume":"1865","author":"Ambudkar","year":"2018","journal-title":"Biochim. Biophys. Acta. Mol. Cell. Res."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247822000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:41:52Z","timestamp":1759045312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247822000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":88,"alternative-id":["S0165247822000955"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2022.06.008","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingosylphosphorylcholine ameliorates experimental sj\u00f6gren's syndrome by regulating salivary gland inflammation and hypofunction, and regulatory B cells","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2022.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}